Not Yet Recruiting
Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC
NCT07047755
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
Not specified